✦ LIBER ✦

Novel Kv1.3 blockers for immunosuppression: WO2012155199

✍ Scribed by Nguyen, William

Book ID: 121256588
Publisher: Informa plc
Year: 2013
Tongue: English
Weight: 426 KB
Volume: 23
Category: Article
ISSN: 1354-3776
DOI: 10.1517/13543776.2013.831072

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enantioselective Total Synthesis of (-)-

Enantioselective Total Synthesis of (-)-Candelalide A, a Novel Blocker of the Voltage-Gated Potassium Channel Kv1.3 for an Immunosuppressive Agent.

✍ Kazuhiro Watanabe; Katsuhiko Iwasaki; Toshiaki Abe; Munenori Inoue; Koichi Ohkub 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 11 KB 👁 2 views

Enantioselective Total Synthesis of (−)-

Enantioselective Total Synthesis of (−)-Candelalide A, a Novel Blocker of the Voltage-Gated Potassium Channel Kv1.3 for an Immunosuppressive Agent

✍ Watanabe, Kazuhiro; Iwasaki, Katsuhiko; Abe, Toshiaki; Inoue, Munenori; Ohkubo, 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 99 KB

Khellinone Derivatives as Blockers of th

Khellinone Derivatives as Blockers of the Voltage-Gated Potassium Channel Kv1.3: Synthesis and Immunosuppressive Activity

✍ Baell, Jonathan B.; Gable, Robert W.; Harvey, Andrew J.; Toovey, Nathan; Herzog, 📂 Article 📅 2004 🏛 American Chemical Society 🌐 English ⚖ 286 KB

Correolide and Derivatives Are Novel Imm

Correolide and Derivatives Are Novel Immunosuppressants Blocking the Lymphocyte Kv1.3 Potassium Channels

✍ Gloria C. Koo; Joseph T. Blake; Kashmira Shah; Mary Jo Staruch; Francis Dumont; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 128 KB

The lymphocyte potassium channels Kv1.3

The lymphocyte potassium channels Kv1.3 and KCa3.1 as targets for immunosuppression

✍ Jenny Lam; Heike Wulff 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

## Abstract The voltage‐gated Kv1.3 and the calcium‐activated KCa3.1 potassium channel modulate many calcium‐dependent cellular processes in immune cells, including T‐cell activation and proliferation and have therefore been proposed as novel therapeutic targets for immunomodulation. Kv1.3 is highl

Tst26, a novel peptide blocker of Kv1.2

Tst26, a novel peptide blocker of Kv1.2 and Kv1.3 channels from the venom of Tityus stigmurus

✍ Ferenc Papp; Cesar V.F. Batista; Zoltan Varga; Monika Herceg; Sergio A. Román-Go 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 938 KB